Browse > Article

Medium-chain Acyl-CoA Dehydrogenase Deficiency in an Asymptomatic Neonate  

Kyung, Yechan (Departments of Pediatrics, Sungkyunkwan University School of Medicine)
Huh, Rimm (Departments of Pediatrics, Sungkyunkwan University School of Medicine)
Kwun, Younghee (Departments of Pediatrics, Sungkyunkwan University School of Medicine)
Lee, Jieun (Departments of Pediatrics, Sungkyunkwan University School of Medicine)
Cho, Sung Yoon (Departments of Pediatrics, Sungkyunkwan University School of Medicine)
Jin, Dong-Kyu (Departments of Pediatrics, Sungkyunkwan University School of Medicine)
Lee, Jeongho (Departments of Pediatrics, Soonchunhyang University School of Medicine)
Lee, Dong Hwan (Departments of Pediatrics, Soonchunhyang University School of Medicine)
Publication Information
Journal of The Korean Society of Inherited Metabolic disease / v.15, no.1, 2015 , pp. 35-39 More about this Journal
Abstract
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common mitochondrial fatty acid oxidation disorder which is inherited as an autosomal recessive pattern. MCAD deficiency is caused by mutations in the ACADM gene; medium-chain acyl-CoA dehydrogenase gene (ACADM; OMIM 607008) on chromosome 1p31 which encodes MCAD, the mitochondrial enzyme which catalyzes the first reaction in beta-oxidation of fatty acids with medium-chain length. Here, we describe one Korean pediatric case of MCAD deficiency, which was diagnosed during newborn screening by tandem mass spectrometry and confirmed by molecular analysis. The level of hexanoyl (C6), octanoyl (C8), decenoyl (C10:1) carnitine, and C8/C2 ratio was elevated. Homogenous c.1189T>A (p.Tyr397Asn) mutation of ACADM gene was identified by direct sequencing. He has been asymptomatic and has shown normal growth and development by 25 months of age without any intervention. There was no episode of metabolic acidosis during follow-up period.
Keywords
Medium chain acyl-CoA dehydrogenase (MCAD); ACADM gene; Tandem mass spectrometry;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Prasad C, Speechley KN, Dyack S, Rupar CA, Chakraborty P, Kronick JB. Incidence of mediumchain acyl-CoA dehydrogenase deficiency in Canada using the Canadian Paediatric Surveillance Program: Role of newborn screening. Paediatr Child Health 2012;17:185-9.   DOI
2 Shigematsu Y, Hirano S, Hata I, Tanaka Y, Sudo M, Sakura N, et al. Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. J Chromatogr B Analyt Technol Biomed Life Sci 2002;776:39-48.   DOI
3 Woo HI, Park HD, Lee YW, Lee DH, Ki CS, Lee SY, et al. Clinical, biochemical and genetic analyses in two Korean patients with medium-chain acyl-CoA dehydrogenase deficiency. Korean J Lab Med 2011;31:54-60.   DOI
4 Yoon HR, Lee KR, Kang S, Lee DH, Yoo HW, Min WK, et al. Screening of newborns and highrisk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Chim Acta 2005;354:167-80.   DOI
5 Ensenauer R, Winters JL, Parton PA, Kronn DF, Kim JW, Matern D, et al. Genotypic differences of MCAD deficiency in the Asian population: novel genotype and clinical symptoms preceding newborn screening notification. Genet Med 2005;7:339-43.   DOI
6 Houten SM, Wanders RJ. A general introduction to the biochemistry of mitochondrial fatty acid betaoxidation. J Inherit Metab Dis 2010;33:469-77.   DOI
7 Iafolla AK, Thompson RJ, Jr., Roe CR. Mediumchain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994;124:409-15.   DOI
8 Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, et al. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr 1998;132:924-33.   DOI
9 Oerton J, Khalid JM, Besley G, Dalton RN, Downing M, Green A, et al. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency in England: prevalence, predictive value and test validity based on 1.5 million screened babies. J Med Screen 2011;18:173-81.   DOI
10 Olpin SE. Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability. J Inherit Metab Dis 2013;36:645-58.   DOI
11 Catarzi S, Caciotti A, Thusberg J, Tonin R, Malvagia S, la Marca G, et al. Medium-chain acyl-CoA deficiency: outlines from newborn screening, in silico predictions, and molecular studies. Scientific World Journal 2013;2013:625824.
12 Wilcken B, Haas M, Joy P, Wiley V, Chaplin M, Black C, et al. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet 2007;369:37-42.   DOI
13 Horvath GA, Davidson AG, Stockler-Ipsiroglu SG, Lillquist YP, Waters PJ, Olpin S, et al. Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada. Can J Public Health 2008;99:276-80.
14 Hsu HW, Zytkovicz TH, Comeau AM, Strauss AW, Marsden D, Shih VE, et al. Spectrum of mediumchain acyl-CoA dehydrogenase deficiency detected by newborn screening. Pediatrics 2008;121:e1108-14.   DOI
15 Derks TG, van Spronsen FJ, Rake JP, van der Hilst CS, Span MM, Smit GP. Safe and unsafe duration of fasting for children with MCAD deficiency. Eur J Pediatr 2007;166:5-11.   DOI
16 Purevsuren J, Kobayashi H, Hasegawa Y, Mushimoto Y, Li H, Fukuda S, et al. A novel molecular aspect of Japanese patients with medium-chain acyl-CoA dehydrogenase deficiency (MCADD): c. 449-452delCTGA is a common mutation in Japanese patients with MCADD. Mol Genet Metab 2009;96:77-9.   DOI
17 Bennett MJ. Pathophysiology of fatty acid oxidation disorders. J Inherit Metab Dis 2010;33:533-7.   DOI
18 Waddell L, Wiley V, Carpenter K, Bennetts B, Angel L, Andresen BS, et al. Medium-chain acyl-CoA dehydrogenase deficiency: genotype-biochemical phenotype correlations. Mol Genet Metab 2006;87:32-9.   DOI
19 Yokoi K, Ito T, Maeda Y, Nakajima Y, Ueta A, Nomura T, et al. Acylcarnitine profiles during carnitine loading and fasting tests in a Japanese patient with medium-chain acyl-CoA dehydrogenase deficiency. Tohoku J Exp Med 2007;213:351-9.   DOI
20 Schatz UA, Ensenauer R. The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population. J Inherit Metab Dis 2010;33:513-20.   DOI